» Articles » PMID: 16610064

Local Regulator Adrenomedullin Contributes to the Circulatory Disturbance in Cirrhotic Rats

Overview
Specialty Gastroenterology
Date 2006 Apr 13
PMID 16610064
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate whether adrenomedullin, a potent vasodilator peptide, plays a role in the circulatory disturbance in cirrhosis.

Methods: Cirrhosis was induced in rats by weekly gavage of carbon tetrachloride. Hemodynamic studies were performed in vivo using radioactive microspheres and in vitro using isolated aortic rings. The adrenomedullin concentrations were measured by radioimmunoassay.

Results: Acute administration of adrenomedullin to the control rats reduced the systemic arterial pressure along with an increase of serum levels of the stable metabolite of nitric oxide (NOx), in a dose-dependent manner. Chronic infusion of adrenomedullin reduced the vascular resistance and increased the blood flow in the systemic and splanchnic circulation. Intravenous administration of anti-adrenomedullin antibody did not affect any hemodynamic parameters in the cirrhotic rats, whereas this antibody ameliorated the blunted contractile response to phenylephrine, alpha-adrenergic receptor agonist, in the aortic rings of the cirrhotic rats. The adrenomedullin concentrations in the aorta were higher in the cirrhotic rats than in the controls, and correlated with the mean arterial pressure in the cirrhotic rats. Moreover, adrenomedullin blunted the contractile response to phenylephrine in both of the control aorta and cirrhotic aorta, but not in the presence of NG-nitro-L-arginine methyl ester, an NO synthase inhibitor.

Conclusion: Adrenomedullin overproduced in the vascular wall may contribute to the circulatory disturbance in cirrhosis as a local regulator of the vascular tonus rather than a circulating hormone.

Citing Articles

Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients.

Kuwano A, Tanaka M, Suzuki H, Kurokawa M, Imoto K, Tashiro S Biochem Biophys Rep. 2021; 27:101068.

PMID: 34307908 PMC: 8283323. DOI: 10.1016/j.bbrep.2021.101068.


Physiopathology of splanchnic vasodilation in portal hypertension.

Martell M, Coll M, Ezkurdia N, Raurell I, Genesca J World J Hepatol. 2010; 2(6):208-20.

PMID: 21160999 PMC: 2999290. DOI: 10.4254/wjh.v2.i6.208.

References
1.
Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H . Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993; 192(2):553-60. DOI: 10.1006/bbrc.1993.1451. View

2.
Fernandez-Rodriguez C, Prada I, Prieto J, Montuenga L, Elssasser T, Quiroga J . Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J Hepatol. 1998; 29(2):250-6. DOI: 10.1016/s0168-8278(98)80010-x. View

3.
Chen Y, Gines P, Yang J, Summer S, Falk S, Russell N . Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology. 2004; 39(4):1075-87. DOI: 10.1002/hep.20151. View

4.
Genesca J, Gonzalez A, Catalan R, Segura R, Martinez M, Esteban R . Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig Dis Sci. 1999; 44(2):372-6. DOI: 10.1023/a:1026618904493. View

5.
Bendtsen F, Schifter S, Henriksen J . Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol. 1991; 12(1):118-23. DOI: 10.1016/0168-8278(91)90920-7. View